With the analysis among 12,030 patents, we discovered top 444 key players by total patent application. Merck Patent GmbH, Novartis AG, Bristol Myers Squibb Co. are dominant in this area. They take 14.29% of the total patent filing.
Hessen, Germany
Patent: 608
Basel-Stadt, Switzerland
Patent: 601
New York, United States
Patent: 510
California, United States
Patent: 441
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 388
F. Hoffmann-La Roche Ltd.
Boehringer Ingelheim Pharma GmbH
New Jersey, United States
Patent: 277
Antwerpen, Belgium
Patent: 244
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 244
With the analysis among 164 patents, we discovered top 26 start-ups by total patent application. Capella Therapeutics, Inc., Institut National de la Santé et de la Recherche Médicale, iOmx Therapeutics AG are active in this area.
Capella Therapeutics, Inc.
California, United States
Patent: 33
Institut National de la Santé et de la Recherche Médicale
Bayern, Germany
Patent: 13
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 12
Ashvattha Therapeutics Inc
California, United States
Patent: 10
Orionis Biosciences, Inc.
Massachusetts, United States
Patent: 9
Enliven Therapeutics, Inc. /US/
Colorado, United States
Patent: 6
TransThera Sciences (Nanjing), Inc.
Jiangsu Sheng, China
Patent: 6
California, United States
Patent: 5
With the analysis among related 1,857 patents applied in the last 5 years. We discover 486 most active companies in this area. The fast-growing Janssen Pharmaceutica NV, Hanmi Pharmaceutical Co., Ltd., Biogen MA, Inc. take 7.11% of patent filing during this period.
Antwerpen, Belgium
Patent: 51
Hanmi Pharmaceutical Co., Ltd.
Massachusetts, United States
Patent: 40
Beijing Scitech-Mq Pharmaceuticals Ltd
Beijing Shi, China
Patent: 28
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 27
The Board of Regents of The University of Texas System
Texas, United States
Patent: 26
New York, United States
Patent: 26
New York, United States
Patent: 26
California, United States
Patent: 24
Memorial Sloan-Kettering Cancer Center
New York, United States
Patent: 23
With the analysis among related 1,857 patents in last 5 years, we discover 273 new entrants. Yaoya Technology (Shanghai) Co., Ltd., Terns, Inc., German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) are the most active new entrants in this area.
Yaoya Technology (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 17
California, United States
Patent: 17
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Yaojie Ankang Nanjing Technology Co Ltd.
Jiangsu Sheng, China
Patent: 14
Ticino, Switzerland
Patent: 14
Beijing Prime Gene Therapeutics Co., Ltd.
Beijing Shi, China
Patent: 13
Bayern, Germany
Patent: 13
Massachusetts, United States
Patent: 12
With the analysis among 1,907 patents, we discovered top 226 universities and scientific research institutions by total patent application. Shanghai Institute of Materia Medica Chinese Academy of Sciences, The University of North Carolina at Chapel Hill, Yale University are dominant in this area. They take 13.84% of the total patent filing.
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 59
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 52
Connecticut, United States
Patent: 48
New York, United States
Patent: 48
The Scripps Research Institute
California, United States
Patent: 47
The Rockefeller University
New York, United States
Patent: 34
The Johns Hopkins University
Institute Of Cancer Research
Regents of the University of Colorado
Colorado, United States
Patent: 22
Korea Institute of Science & Technology